Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Chabaud

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
The Lancet. Oncology|January 8, 2020
Androgen deprivation therapy plus salvage radiotherapy after prostatectomy - Authors' replyChristian Carrie, Sylvie Chabaud
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectorisSylvie Chabaud, Pascal Girard, Patrice Nony, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2021
Response to letter entitled: Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II studyFlorence Duffaud, Camille Schiffler, Sylvie Chabaud, et al.
Acta Cardiologica|May 13, 2005
Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aortaEric Bonnefoy, Patrick Godon, Gilbert Kirkorian, et al.
Diabetes Care|March 1, 2003
Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) studyLaurent Vaur, Pascal Gueret, Michel Lievre, et al.
The Lancet. Oncology|October 31, 2024
Omitting study limitations might have implications for the patients - Authors' replyJean-Yves Blay, Sylvie Chabaud, David Perol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R SoftwareAudrey Emmanuelle Dugué, Marina Pulido, Sylvie Chabaud, et al.
Contemporary Clinical Trials|July 7, 2009
Revisiting the level of evidence in randomized controlled clinical trials: A simulation approachAgathe Bajard, Sylvie Chabaud, David Pérol, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2007
Active breathing control for Hodgkin's disease in childhood and adolescence: feasibility, advantages, and limitsLine Claude, Claude Malet, Pascal Pommier, et al.
Clinical Pharmacokinetics|January 25, 2006
Compliance-guided therapy : a new insight into the potential role of clinical pharmacologistsAlexia Blesius, Sylvie Chabaud, Michel Cucherat, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
The Lancet. Oncology|January 8, 2020
Androgen deprivation therapy plus salvage radiotherapy after prostatectomy - Authors' replyChristian Carrie, Sylvie Chabaud
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectorisSylvie Chabaud, Pascal Girard, Patrice Nony, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2021
Response to letter entitled: Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II studyFlorence Duffaud, Camille Schiffler, Sylvie Chabaud, et al.
Acta Cardiologica|May 13, 2005
Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aortaEric Bonnefoy, Patrick Godon, Gilbert Kirkorian, et al.
Diabetes Care|March 1, 2003
Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) studyLaurent Vaur, Pascal Gueret, Michel Lievre, et al.
The Lancet. Oncology|October 31, 2024
Omitting study limitations might have implications for the patients - Authors' replyJean-Yves Blay, Sylvie Chabaud, David Perol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R SoftwareAudrey Emmanuelle Dugué, Marina Pulido, Sylvie Chabaud, et al.
Contemporary Clinical Trials|July 7, 2009
Revisiting the level of evidence in randomized controlled clinical trials: A simulation approachAgathe Bajard, Sylvie Chabaud, David Pérol, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2007
Active breathing control for Hodgkin's disease in childhood and adolescence: feasibility, advantages, and limitsLine Claude, Claude Malet, Pascal Pommier, et al.
Clinical Pharmacokinetics|January 25, 2006
Compliance-guided therapy : a new insight into the potential role of clinical pharmacologistsAlexia Blesius, Sylvie Chabaud, Michel Cucherat, et al.
Pageof 15